Ibere Pharmaceuticals - Class A
IBER
Get informed when a big investor buys or sells
+ FollowMarket Cap$175.61M
Close$
Share Statistics
| Market cap | $175.61 Million |
|---|---|
| Enterprise Value | $175.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.34 |
| Beta | 0 |
| Outstanding Shares | 17,250,000 |
Return
| Return on Equity | 10.08% |
|---|---|
| Return on Assets | 9.65% |
| Return on Invested Capital | -0.75% |
Valuation & Multiples
| P/E Ratio | 74.91 |
|---|---|
| PEG | 1580.8 |
| Price to Sales | - |
| Price to Book Ratio | 1.45 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -169.46 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Ibere Pharmaceuticals
3 employeesIbere Pharmaceuticals is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Although...